Benitec Biopharma Ltd Stock Price on December 6, 2024
| BNTC Stock | USD 11.62 0.00 0.00% |
Below is the normalized historical share price chart for Benitec Biopharma Ltd extending back to June 23, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Benitec Biopharma stands at 11.62, as last reported on the 18th of December 2024, with the highest price reaching 12.76 and the lowest price hitting 11.62 during the day.
If you're considering investing in Benitec Stock, it is important to understand the factors that can impact its price. Benitec Biopharma appears to be moderately volatile, given 3 months investment horizon. Benitec Biopharma secures Sharpe Ratio (or Efficiency) of 0.14, which signifies that the company had a 0.14% return per unit of risk over the last 3 months. By analyzing Benitec Biopharma's technical indicators, you can evaluate if the expected return of 0.74% is justified by implied risk. Please makes use of Benitec Biopharma's Mean Deviation of 3.95, downside deviation of 3.74, and Risk Adjusted Performance of 0.1159 to double-check if our risk estimates are consistent with your expectations.
At present, Benitec Biopharma's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 54.8 M, whereas Common Stock Total Equity is forecasted to decline to 855.00. . As of December 18, 2024, Price To Sales Ratio is expected to decline to 75.45. In addition to that, Price Earnings Ratio is expected to decline to -1.42. Benitec Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of August 2015 | 200 Day MA 7.6405 | 50 Day MA 9.7691 | Beta 0.879 |
Benitec |
Sharpe Ratio = 0.1352
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BNTC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.49 actual daily | 48 52% of assets are more volatile |
Expected Return
| 0.74 actual daily | 14 86% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average Benitec Biopharma is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Benitec Biopharma by adding it to a well-diversified portfolio.
Price Book 4.5507 | Enterprise Value Ebitda 0.2655 | Price Sales 2.8 K | Shares Float 3.9 M | Wall Street Target Price 24 |
Related Headline
ZyVersa Therapeutics Headline on 6th of December 2024
Acquisition by Stephen Glover of 79417 shares of ZyVersa The... by Stephen Glover
Filed transaction by ZyVersa Therapeutics Officer Chief Executive Officer. Grant, award or other acquisition pursuant to Rule 16b-3
Benitec Biopharma Valuation on December 6, 2024
It is possible to determine the worth of Benitec Biopharma on a given historical date. On December 6, 2024 Benitec was worth 9.83 at the beginning of the trading date compared to the closed value of 11.23. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Benitec Biopharma stock. Still, in general, we apply an absolute valuation method to find Benitec Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Benitec Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Benitec Biopharma's related companies.
| Open | High | Low | Close | Volume | |
| 9.92 | 10.00 | 9.49 | 9.78 | 23,254 | |
12/06/2024 | 9.83 | 11.24 | 9.73 | 11.23 | 74,122 |
| 11.35 | 13.18 | 11.35 | 12.18 | 122,752 |
| Backtest Benitec Biopharma | | | Benitec Biopharma History | | | Benitec Biopharma Valuation | Previous | Next |
Benitec Biopharma Trading Date Momentum on December 6, 2024
| On December 09 2024 Benitec Biopharma Ltd was traded for 12.18 at the closing time. The top price for the day was 13.18 and the lowest listed price was 11.35 . The trading volume for the day was 122.8 K. The trading history from December 9, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 8.46% . The overall trading delta against the current closing price is 6.86% . |
Benitec Biopharma Fundamentals Correlations and Trends
By evaluating Benitec Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Benitec Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Benitec financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Benitec Biopharma Stock history
Benitec Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Benitec is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Benitec Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Benitec Biopharma stock prices may prove useful in developing a viable investing in Benitec Biopharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4.1 M | 4.3 M | |
| Net Loss | -17.6 M | -18.5 M |
Benitec Biopharma Stock Technical Analysis
Benitec Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Benitec Biopharma Period Price Range
Low | December 18, 2024
| High |
0.00 | 0.00 |
Benitec Biopharma Ltd cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Benitec Biopharma December 18, 2024 Market Strength
Market strength indicators help investors to evaluate how Benitec Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Benitec Biopharma shares will generate the highest return on investment. By undertsting and applying Benitec Biopharma stock market strength indicators, traders can identify Benitec Biopharma Ltd entry and exit signals to maximize returns
Benitec Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Benitec Biopharma's price direction in advance. Along with the technical and fundamental analysis of Benitec Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Benitec to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1159 | |||
| Jensen Alpha | 0.7986 | |||
| Total Risk Alpha | 0.358 | |||
| Sortino Ratio | 0.1946 | |||
| Treynor Ratio | (3.69) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Benitec Stock analysis
When running Benitec Biopharma's price analysis, check to measure Benitec Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Benitec Biopharma is operating at the current time. Most of Benitec Biopharma's value examination focuses on studying past and present price action to predict the probability of Benitec Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Benitec Biopharma's price. Additionally, you may evaluate how the addition of Benitec Biopharma to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |